Epidemiology of Clostridium difficile infection in Asia

Antimicrobial Resistance and Infection Control

Volumn 2, Issue 1, 2013, Pages

  Collins, Deirdre A ^a   Hawkey, Peter M ^b,c   Riley, Thomas V ^a,d  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

Clostridium Difficile; Clostridium Infections In Humans; Epidemiology

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CIPROFLOXACIN; CLINDAMYCIN; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; ERYTHROMYCIN; METRONIDAZOLE; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; PROTON PUMP INHIBITOR; TETRACYCLINE; VANCOMYCIN;

AMEBIASIS; ANTIBIOTIC ASSOCIATED DIARRHEA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ASIA; BACTERIAL STRAIN; BACTERIUM ISOLATE; BANGLADESH; CHINA; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE SURVEILLANCE; DRUG USE; ENZYME IMMUNOASSAY; EPIDEMIC; FECES CULTURE; HEALTH CARE ACCESS; HIGH RISK POPULATION; HONG KONG; HUMAN; INDIA; INDONESIA; INFECTION CONTROL; JAPAN; KOREA; MALAYSIA; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; PHILIPPINES; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RECURRENT INFECTION; REVIEW; RISK FACTOR; SINGAPORE; TAIWAN; THAILAND; TOXIN ANALYSIS;

EID: 84893029746     PISSN: None     EISSN: 20472994     Source Type: Journal    
DOI: 10.1186/2047-2994-2-21     Document Type: Review

References (83)

1. Clements AC, Magalhaes RJ, Tatem AJ, Paterson DL, Riley TV. Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread. Lancet Infect Dis 2010, 10(6):395-404. 10.1016/S1473-3099(10)70080-3, 20510280.
2. Al-Barrak A, Embil J, Dyck B, Olekson K, Nicoll D, Alfa M, Kabani A. An outbreak of toxin A negative, toxin B positive Clostridium difficile-associated diarrhea in a Canadian tertiary-care hospital. Can Commun Dis Rep 1999, 25(7):65-69.
3. Kuijper E, Weerdt J, Kato H, Kato N, Dam A, Vorm E, Weel J, Rheenen C, Dankert J. Nosocomial outbreak of Clostridium difficile-associated diarrhoea due to a clindamycin-resistant enterotoxin A-negative strain. Eur J Clin Microbiol Infect Dis 2001, 20(8):528-534.
4. Drudy D, Harnedy N, Fanning S, Hannan M, Kyne L. Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile. Infect Control Hosp Epidemiol 2007, 28(8):932-940. 10.1086/519181, 17620240.
5. Mavros MN, Alexiou VG, Vardakas KZ, Tsokali K, Sardi TA, Falagas ME. Underestimation of Clostridium difficile infection among clinicians: an international survey. Eur J Clin Microbiol Infect Dis 2012, 31(9):2439-2444. 10.1007/s10096-012-1587-9, 22450740.
6. Kato H, Kato N, Watanabe K, Iwai N, Nakamura H, Yamamoto T, Suzuki K, Kim S-M, Chong Y, Wasito EB. Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. J Clin Microbiol 1998, 36(8):2178-2182. 105000, 9665986.
7. Kato H, Kato N, Katow S, Maegawa T, Nakamura S, Lyerly DM. Deletions in the repeating sequences of the toxin A gene of toxin A-negative, toxin B-positive Clostridium difficile strains. FEMS Microbiol Lett 1999, 175(2):197-203. 10.1111/j.1574-6968.1999.tb13620.x, 10386368.
8. Kato H, Kato N, Watanabe K, Yamamoto T, Suzuki K, Ishigo S, Kunihiro S, Nakamura I, Killgore GE, Nakamura S. Analysis of Clostridium difficile isolates from nosocomial outbreaks at three hospitals in diverse areas of Japan. J Clin Microbiol 2001, 39(4):1391-1395. 10.1128/JCM.39.4.1391-1395.2001, 87944, 11283061.
9. Kato H, Kita H, Karasawa T, Maegawa T, Koino Y, Takakuwa H, Saikai T, Kobayashi K, Yamagishi T, Nakamura S. Colonisation and transmission of Clostridium difficile in healthy individuals examined by PCR ribotyping and pulsed-field gel electrophoresis. J Med Microbiol 2001, 50(8):720-727.
10. Kato H, Yokoyama T, Arakawa Y. Typing by sequencing the slpA gene of Clostridium difficile strains causing multiple outbreaks in Japan. J Med Microbiol 2005, 54(Pt 2):167-171.
11. Komatsu M, Kato H, Aihara M, Shimakawa K, Iwasaki M, Nagasaka Y, Fukuda S, Matsuo S, Arakawa Y, Watanabe M, et al. High frequency of antibiotic-associated diarrhea due to toxin A-negative, toxin B-positive Clostridium difficile in a hospital in Japan and risk factors for infection. Eur J Clin Microbiol Infect Dis 2003, 22(9):525-529. 10.1007/s10096-003-0992-5, 12938013.
12. van den Berg RJ, Claas EC, Oyib DH, Klaassen CH, Dijkshoorn L, Brazier JS, Kuijper EJ. Characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates from outbreaks in different countries by amplified fragment length polymorphism and PCR ribotyping. J Clin Microbiol 2004, 42(3):1035-1041. 10.1128/JCM.42.3.1035-1041.2004, 356898, 15004050.
13. Kikkawa H, Hitomi S, Watanabe M. Prevalence of toxin A-nonproducing/toxin-B-producing Clostridium difficile in the Tsukuba-Tsuchiura district. Japan. J Infect Chemother 2007, 13(1):35-38.
14. Iwashima Y, Nakamura A, Kato H, Wakimoto Y, Wakiyama N, Kaji C, Ueda R. A retrospective study of the epidemiology of Clostridium difficile infection at a University Hospital in Japan: genotypic features of the isolates and clinical characteristics of the patients. J Infect Chemother 2010, 16(5):329-333. 10.1007/s10156-010-0066-4, 20449624.
15. Rupnik M, Kato N, Grabnar M, Kato H. New types of toxin A-negative, toxin B-positive strains among Clostridium difficile isolates from Asia. J Clin Microbiol 2003, 41(3):1118-1125. 10.1128/JCM.41.3.1118-1125.2003, 150296, 12624039.
16. Sawabe E, Kato H, Osawa K, Chida T, Tojo N, Arakawa Y, Okamura N. Molecular analysis of Clostridium difficile at a university teaching hospital in Japan: a shift in the predominant type over a five-year period. Eur J Clin Microbiol Infect Dis 2007, 26(10):695-703. 10.1007/s10096-007-0355-8, 17647032.
17. Kato H, Kato H, Ito Y, Akahane T, Izumida S, Yokoyama T, Kaji C, Arakawa Y. Typing of Clostridium difficile isolates endemic in Japan by sequencing of slpA and its application to direct typing. J Med Microbiol 2010, 59(Pt 5):556-562.
18. Kato H, Kato H, Nakamura M, Iwashima Y, Nakamura A, Ueda R. Rapid analysis of Clostridium difficile strains recovered from hospitalized patients by using the slpA sequence typing system. J Infect Chemother 2009, 15(3):199-202. 10.1007/s10156-009-0681-0, 19554407.
19. Kim J, Kang JO, Kim H, Seo MR, Choi TY, Pai H, Kuijper EJ, Sanders I, Fawley W. Epidemiology of Clostridium difficile infections in a tertiary-care hospital in Korea. Clin Microbiol Infect 2013, 19(6):521-527. 10.1111/j.1469-0691.2012.03910.x, 22712697.
20. Bauer MP, Notermans DW, van Benthem BHB, Brazier JS, Wilcox MH, Rupnik M, Monnet DL, van Dissel JT, Kuijper EJ. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 2011, 377(9759):63-73. 10.1016/S0140-6736(10)61266-4, 21084111.
21. Spigaglia P, Barbanti F, Dionisi AM, Mastrantonio P. Clostridium difficileisolates resistant to fluoroquinolones in Italy: emergence of PCR ribotype 018. J Clin Microbiol 2010, 48(8):2892-2896. 10.1128/JCM.02482-09, 2916588, 20554809.
22. Kim YS, Han DS, Kim YH, Kim WH, Kim JS, Kim HS, Park YS, Song HJ, Shin SJ, Yang SK, et al. Incidence and clinical features of Clostridium difficile infection in Korea: a nationwide study. Epidemiol Infect 2013, 141(1):189-194. 10.1017/S0950268812000581, 22717061.
23. Ryu HS, Kim YS, Seo GS, Lee YM, Choi SC. Risk factors for recurrent Clostridium difficile infection. Intest Res 2012, 10(2):176-182.
24. Kim YG, Graham DY, Jang BI. Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score. J Clin Gastroenterol 2012, 46(5):397-400. 10.1097/MCG.0b013e3182431d78, 22298089.
25. Choi HK, Kim KH, Lee SH, Lee SJ. Risk factors for recurrence of Clostridium difficile infection: Effect of vancomycin-resistant Enterococci colonization. J Korean Med Sci 2011, 26(7):859-864. 10.3346/jkms.2011.26.7.859, 3124713, 21738336.
26. Shin BM, Moon SJ, Kim YS, Shin WC, Yoo HM. Characterization of cases of Clostridium difficile infection (CDI) presenting at an emergency room: Molecular and clinical features differentiate community-onset hospital-associated and community-associated CDI in a tertiary care hospital. J Clin Microbiol 2011, 49(6):2161-2165. 10.1128/JCM.02330-10, 3122747, 21471341.
27. Kim H, Riley TV, Kim M, Kim CK, Yong D, Lee K, Chong Y, Park JW. Increasing prevalence of toxin A-negative, toxin B-positive isolates of Clostridium difficile in Korea: impact on laboratory diagnosis. J Clin Microbiol 2008, 46(3):1116-1117. 10.1128/JCM.01188-07, 2268382, 18199783.
28. Shin BM, Kuak EY, Yoo HM, Kim EC, Lee K, Kang JO, Whang DH, Shin JH. Multicentre study of the prevalence of toxigenic Clostridium difficile in Korea: results of a retrospective study 2000-2005. J Med Microbiol 2008, 57(Pt 6):697-701.
29. Shin BM, Kuak EY, Yoo SJ, Shin WC, Yoo HM. Emerging toxin A-B + variant strain of Clostridium difficile responsible for pseudomembranous colitis at a tertiary care hospital in Korea. Diagn Microbiol Infect Dis 2008, 60(4):333-337. 10.1016/j.diagmicrobio.2007.10.022, 18082994.
30. Shin BM, Lee EJ, Kuak EY, Yoo SJ. Comparison of VIDAS CDAB and CDA immunoassay for the detection of Clostridium difficile in a tcdA- tcdB + C. difficile prevalent area. Anaerobe 2009, 15(6):266-269. 10.1016/j.anaerobe.2009.09.008, 19772927.
31. Kim H, Jeong SH, Roh KH, Hong SG, Kim JW, Shin MG, Kim MN, Shin HB, Uh Y, Lee H, et al. Investigation of toxin gene diversity, molecular epidemiology, and antimicrobial resistance of Clostridium difficile isolated from 12 hospitals in South Korea. Korean J Lab Med 2010, 30(5):491-497. 10.3343/kjlm.2010.30.5.491, 20890081.
32. Kim SJ, Kim H, Seo Y, Yong D, Jeong SH, Chong Y, Lee K. Molecular characterization of toxin A-negative, toxin B-positive variant strains of Clostridium difficile isolated in Korea. Diagn Microbiol Infect Dis 2010, 67(2):198-201. 10.1016/j.diagmicrobio.2010.01.007, 20338708.
33. Kim J, Kang JO, Pai H, Choi TY. Association between PCR ribotypes and antimicrobial susceptibility among Clostridium difficile isolates from healthcare-associated infections in South Korea. Int J Antimicrob Agents 2012, 40(1):24-29. 10.1016/j.ijantimicag.2012.03.015, 22578765.
34. Kim H, Lee Y, Moon HW, Lim CS, Lee K, Chong Y. Emergence of Clostridium difficile ribotype 027 in Korea. Korean J Lab Med 2011, 31(3):191-196. 10.3343/kjlm.2011.31.3.191, 3129351, 21779194.
35. Jin K, Wang S, Huang Z, Lu S. Clostridium difficile infections in China. Journal of Biomedical Research 2010, 24(6):411-416. 10.1016/S1674-8301(10)60055-3, 3596688, 23554657.
36. Huang H, Wu S, Wang M, Zhang Y, Fang H, Palmgren AC, Weintraub A, Nord CE. Molecular and clinical characteristics of Clostridium difficile infection in a University Hospital in Shanghai. China. Clin Infect Dis 2008, 47(12):1606-1608.
37. Huang H, Fang H, Weintraub A, Nord CE. Distinct ribotypes and rates of antimicrobial drug resistance in Clostridium difficile from Shanghai and Stockholm. Clin Microbiol Infect 2009, 15(12):1170-1173. 10.1111/j.1469-0691.2009.02992.x, 19624517.
38. Huang H, Wu S, Wang M, Zhang Y, Fang H, Palmgren AC, Weintraub A, Nord CE. Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes. Int J Antimicrob Agents 2009, 33(4):339-342. 10.1016/j.ijantimicag.2008.09.022, 19097757.
39. Huang H, Weintraub A, Fang H, Wu S, Zhang Y, Nord CE. Antimicrobial susceptibility and heteroresistance in Chinese Clostridium difficile strains. Anaerobe 2010, 16(6):633-635. 10.1016/j.anaerobe.2010.09.002, 20849968.
40. Cheng V, Yam W, Lam O, Tsang J, Tse E, Siu G, Chan J, Tse H, To K, Tai J, et al. Clostridium difficile isolates with increased sporulation: emergence of PCR ribotype 002 in Hong Kong. Eur J Clin Microbiol Infect Dis 2011, 30(11):1371-1381. 10.1007/s10096-011-1231-0, 3191290, 21468685.
41. Yan Q, Zhang J, Chen C, Zhou H, Du P, Cui Z, Cen R, Liu L, Li W, Cao B, et al. Multilocus sequence typing (MLST) analysis of 104 Clostridium difficile strains isolated from China. Epidemiol Infect 2013, 141(1):195-199. 10.1017/S0950268812000453, 22475233.
42. Dingle KE, Griffiths D, Didelot X, Evans J, Vaughan A, Kachrimanidou M, Stoesser N, Jolley KA, Golubchik T, Harding RM, et al. Clinical Clostridium difficile: Clonality and pathogenicity locus diversity. PLoS One 2011, 6(5):e19993. 10.1371/journal.pone.0019993, 3098275, 21625511.
43. Chang SC, Su CH, Chou WH, Hwang KP, Chuang YC, Chou MY, Leu HS, Wang FD, Wang JT, Wang LS, et al. Epidemiology of nosocomial Clostridium difficile disease in Taiwan. Taiwan Epidemiology Bulletin 2009, 25(3):163-177.
44. Chan YY, Lin TY, Huang CT, Deng ST, Wu TL, Leu HS, Chiu CH. Implementation and outcomes of a hospital-wide computerised antimicrobial stewardship programme in a large medical centre in Taiwan. Int J Antimicrob Agents 2011, 38(6):486-492. 10.1016/j.ijantimicag.2011.08.011, 21982143.
45. Lee YC, Wang JT, Chen AC, Sheng WH, Chang SC, Chen YC. Changing incidence and clinical manifestations of Clostridium difficile-associated diarrhea detected by combination of glutamate dehydrogenase and toxin assay in Northern Taiwan. J Microbiol Immunol Infect 2012, 45(4):287-295. 10.1016/j.jmii.2011.12.001, 22209696.
46. Wei HL, Kao CW, Wei SH, Tzen JT, Chiou CS. Comparison of PCR ribotyping and multilocus variable-number tandem-repeat analysis (MLVA) for improved detection of Clostridium difficile. BMC Microbiol 2011, 11(1):217. 10.1186/1471-2180-11-217, 3191483, 21961456.
47. Lin YC, Huang YT, Tsai PJ, Lee TF, Lee NY, Liao CH, Lin SY, Ko WC, Hsueh PR. Antimicrobial susceptibilities and molecular epidemiology of clinical isolates of Clostridium difficile in Taiwan. Antimicrob Agents Chemother 2011, 55(4):1701-1705. 10.1128/AAC.01440-10, 3067156, 21263053.
48. Wong SSY, Ho PL, Woo PCY, Yuen KY. Bacteremia caused by Staphylococci with inducible vancomycin heteroresistance. Clin Infect Dis 1999, 29(4):760-767. 10.1086/520429, 10589883.
49. Cheng VC, Yam WC, Chan JF, To KK, Ho PL, Yuen KY. Clostridium difficile ribotype 027 arrives in Hong Kong. Int J Antimicrob Agents 2009, 34(5):492-493. 10.1016/j.ijantimicag.2009.04.004, 19464857.
50. Warren CA, Labio E, Destura R, Sevilleja JE, Jamias JD, Daez ML. Clostridium difficile and Entamoeba histolytica infections in patients with colitis in the Philippines. Trans R Soc Trop Med Hyg 2012, 106(7):424-428. 10.1016/j.trstmh.2012.04.005, 22657531.
51. Wongwanich S, Ramsiri S, Vanasin B, Khowsaphit P, Tantipatayangkul P, Phan-urai R. Clostridium difficile associated disease in Thailand. Southeast Asian J Trop Med Public Health 1990, 21(3):367-372.
52. Thamlikitkul V, Danpakdi K, Chokloikaew S. Incidence of diarrhea and Clostridium difficile toxin in stools from hospitalized patients receiving clindamycin, beta-lactams, or nonantibiotic medications. J Clin Gastroenterol 1996, 22(2):161-163. 10.1097/00004836-199603000-00024, 8742665.
53. Wongwanich S, Rugdeekha S, Pongpech P, Dhiraputra C. Detection of Clostridium difficile toxin A and B genes from stool samples of Thai diarrheal patients by polymerase chain reaction technique. JMed Assoc Thai 2003, 86(10):970-975.
54. Chotiprasitsakul D, Janvilisri T, Kiertiburanakul S, Watcharananun S, Chankhamhaengdecha S, Hadpanus P, Malathum K. A superior test for diagnosis of Clostridium difficile-associated diarrhea in resource-limited settings. Jpn J Infect Dis 2012, 65(4):326-329. 10.7883/yoken.65.326, 22814157.
55. Wongwanich S, Ramsiri S, Kusum M, Warachit P. Clostridium difficile infections in HIV-positive patients. Southeast Asian J Trop Med Public Health 2000, 31(3):537-539.
56. Waywa D, Kongkriengdaj S, Chaidatch S, Tiengrim S, Kowadisaiburana B, Chaikachonpat S, Suwanagool S, Chaiprasert A, Curry A, Bailey W, et al. Protozoan enteric infection in AIDS related diarrhea in Thailand. Southeast Asian J Trop Med Public Health 2001, 32(Suppl 2):151-155.
57. Wongwanich S, Pongpech P, Dhiraputra C, Huttayananont S, Sawanpanyalert P. Characteristics of Clostridium difficile strains isolated from asymptomatic individuals and from diarrheal patients. Clin Microbiol Infect 2001, 7(8):438-441. 10.1046/j.1198-743x.2001.00308.x, 11591208.
58. Hassan SA, Othman N, Idris FM, Abdul Rahman Z, Maning N, Abdul Rahman R, Tiong CG. Prevalence of Clostridium difficile toxin in diarhoeal stool samples of patients from a tertiary hospital in North Eastern Peninsular Malaysia. Med J Malaysia 2012, 67(4):402-405.
59. Oyofo BA, Subekti D, Tjaniadi P, Machpud N, Komalarini S, Setiawan B, Simanjuntak C, Punjabi N, Corwin AL, Wasfy M, et al. Enteropathogens associated with acute diarrhea in community and hospital patients in Jakarta. Indonesia. FEMS Immunol Med Microbiol 2002, 34(2):139-146.
60. Koh TH, Tan AL, Tan ML, Wang G, Song KP. Epidemiology of Clostridium difficile infection in a large teaching hospital in Singapore. Pathology (Phila) 2007, 39(4):438-442.
61. Lim PL, Barkham TM, Ling LM, Dimatatac F, Alfred T, Ang B. Increasing incidence of Clostridium difficile-associated disease, Singapore. Emerg Infect Dis 2008, 14(9):1487-1489. 10.3201/eid1409.070043, 2603103, 18760029.
62. Hsu LY, Tan TY, Koh TH, Kwa AL, Krishnan P, Tee NW, Jureen R. Decline in Clostridium difficile-associated disease rates in Singapore public hospitals, 2006 to 2008. BMC Res Notes 2011, 4(1):77. 10.1186/1756-0500-4-77, 3068971, 21429188.
63. Lim PL, Ling ML, Lee HY, Koh TH, Tan AL, Kuijper EJ, Goh SS, Low BS, Ang LP, Harmanus C, et al. Isolation of the first three cases of Clostridium difficile polymerase chain reaction ribotype 027 in Singapore. Singapore Med J 2011, 52(5):361-364.
64. Ayyagari A, Sharma P, Venkateswarlu, Mehta S, Agarwal KC. Prevalence of Clostridium difficile in pseudomembranous and antibiotic-associated colitis in north India. J Diarrhoeal Dis Res 1986, 4(3):157-160.
65. Niyogi SK, Bhattacharya SK, Dutta P, Naik TN, De SP, Sen D, Saha MR, Datta D, Nair GB, Mitra U, et al. Prevalence of Clostridium difficile in hospitalised patients with acute diarrhoea in Calcutta. J Diarrhoeal Dis Res 1991, 9(1):16-19.
66. Dhawan B, Chaudhry R, Sharma N. Incidence of Clostridium difficile infection: a prospective study in an Indian hospital. J Hosp Infect 1999, 43(4):275-280. 10.1016/S0195-6701(99)90423-1, 10658803.
67. Chaudhry R, Joshy L, Kumar L, Dhawan B. Changing pattern of Clostridium difficile associated diarrhoea in a tertiary care hospital: a 5 year retrospective study. Indian J Med Res 2008, 127(4):377-382.
68. Ingle M, Deshmukh A, Desai D, Abraham P, Joshi A, Rodrigues C, Mankeshwar R. Prevalence and clinical course of Clostridium difficile infection in a tertiary-care hospital: a retrospective analysis. Indian J Gastroenterol 2011, 30(2):89-93. 10.1007/s12664-011-0097-5, 21553102.
69. Vaishnavi C, Singh M. Preliminary investigation of environmental prevalence of Clostridium difficile affecting inpatients in a north Indian hospital. Indian J Med Microbiol 2012, 30(1):89-92. 10.4103/0255-0857.93052, 22361768.
70. Niyogi SK, Dutta P, Dutta D, Mitra U, Sikdar S. Clostridium difficile and its cytotoxin in hospitalized children with acute diarrhea. Indian Pediatr 1991, 28(10):1129-1132.
71. Gogate A, De A, Nanivadekar R, Mathur M, Saraswathi K, Jog A, Kulkarni MV. Diagnostic role of stool culture & toxin detection in antibiotic associated diarrhoea due to Clostridium difficile in children. Indian J Med Res 2005, 122(6):518-524.
72. Chandra BK, Singh G, Taneja N, Pahil S, Singhi S, Sharma M. Diarrhoeagenic Escherichia coli as a predominant cause of paediatric nosocomial diarrhoea in India. J Med Microbiol 2012, 61(Pt 6):830-836.
73. Albert MJ, Faruque AS, Faruque SM, Sack RB, Mahalanabis D. Case-control study of enteropathogens associated with childhood diarrhea in Dhaka. Bangladesh. J Clin Microbiol 1999, 37(11):3458-3464.
74. Kato H, Ito Y, van den Berg RJ, Kuijper EJ, Arakawa Y. First isolation of Clostridium difficile 027 in Japan. Euro Surveill 2007, 12(1). E070111.070113.
75. Chen W, Liu L. Future population trends in China: 2005-2050. The Centre of Policy Studies (COPS) 2009, Monash University: Australia.
76. Holloway KA. Promoting the rational use of antibiotics. Regional Health Forum. WHO South East Asia Region 2011, 15(1):122-130.
77. Oka K, Osaki T, Hanawa T, Kurata S, Okazaki M, Manzoku T, Takahashi M, Tanaka M, Taguchi H, Watanabe T, et al. Molecular and microbiological characterization of Clostridium difficile isolates from single, relapse, and reinfection cases. J Clin Microbiol 2012, 50(3):915-921. 10.1128/JCM.05588-11, 3295180, 22205786.
78. Kim J, Pai H, Kang J, Seo M-R. Clinical and microbiologic characteristics of tcdA-negative variant Clostridium difficile infections. BMC Infect Dis 2012, 12(1):109. 10.1186/1471-2334-12-109, 3420311, 22571633.
79. Dong D, Zhang L, Chen X, Jiang C, Yu B, Wang X, Peng Y. Antimicrobial susceptibility and resistance mechanisms of clinical Clostridium difficile from a Chinese tertiary hospital. Int J Antimicrob Agents 2013, 41(1):80-84. 10.1016/j.ijantimicag.2012.08.011, 23148985.
80. Nam K-C, Jo C, Lee M. Meat products and consumption culture in the East. Meat Sci 2010, 86(1):95-102. 10.1016/j.meatsci.2010.04.026, 20510536.
81. Coker RJ, Hunter BM, Rudge JW, Liverani M, Hanvoravongchai P. Emerging infectious diseases in southeast Asia: regional challenges to control. Lancet 2011, 377(9765):599-609. 10.1016/S0140-6736(10)62004-1, 21269678.
82. Niwa H, Kato H, Senoh M, Hobo S, Kinoshita Y, Hariu K, Oku K, Kuroda T, Nakai K. Isolation of PCR ribotype 078 Clostridium difficile from five cases of fulminant colitis in thoroughbred racehorses. 4th International Clostridium difficile Symposium 2012, Slovenia: Bled.
83. Asai T, Usui M, Hiki M, Kawanishi M, Nagai H, Sasaki Y. Clostridium difficile isolated from the fecal contents of s wine in Japan. J Vet Med Sci 2013, 75(4):539-541. 10.1292/jvms.12-0353, 23171688.